Mohamed Ghoweba

Dr. Mohamed Ghoweba

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
MAMahmoud Al-Kofahi
Mahmoud Al-Kofahi
Seiichi OmuraSeiichi Omura
Seiichi Omura
ITIkuo Tsunoda
Ikuo Tsunoda
Fumitaka SatoFumitaka Sato
Fumitaka Sato
FBFelix Becker
Felix Becker
Jonathan Steven AlexanderJonathan Steven Alexander
Jonathan Steven Alexander

25 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SBSyed Bukhari
Syed Bukhari
SKSyed Zamrak Khan
Syed Zamrak Khan
MGMohamed Ghoweba
Mohamed Ghoweba
BKBilal Khan
Bilal Khan
ZBZubair Bashir
Zubair Bashir
Cardiac amyloidosis is caused by amyloid fibrils that deposit in the myocardial interstitium, causing restrictive cardiomyopathy and eventually death. The electromechanical, inflammatory, and autonomic changes due to amyloid deposition result in arrhythmias. Atrial fibrillation is by far the most common arrhythmia. The rate control strategy is generally poorly tolerated due to restrictive filling physiology and heart rate dependance, favoring adoption of the rhythm control strategy. Anticoagulation for stroke prophylaxis is warranted, irrespective of CHA2DS2-VASc score in patients with a favorable bleeding profile; data on left appendage closure devices are still insufficient. Ventricular arrhythmias are also not uncommon, and the role of implantable cardioverter-defibrillator in cardiac amyloidosis is controversial. There is no evidence of improvement in outcomes when used for primary prevention in these patients. Bradyarrhythmia is most commonly associated with sudden cardiac death in cardiac amyloidosis. Pacemaker implantation can help provide symptomatic relief but does not confer mortality benefit.

19 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FAFahad Alkhalfan
Fahad Alkhalfan
SBSyed Bukhari
Syed Bukhari
ARAkiva Rosenzveig
Akiva Rosenzveig
RMRohitha Moudgal
Rohitha Moudgal
SKSyed Zamrak Khan
Syed Zamrak Khan
LTLeben Tefera
Leben Tefera
Background: While obesity is associated with an increased risk of venous thromboembolism (VTE), there is some data to suggest that higher BMI is also associated with decreased all-cause mortality in patients with a pulmonary embolism (PE). Methods: Using PE Response Team (PERT) activation data from a large tertiary hospital between 27 October 2020 and 28 August 2023, we constructed a multivariate Cox proportional hazards model to assess the association between obesity as a dichotomous variable (defined as BMI ≥ 30 vs. BMI 18.5–29.9), BMI as a continuous variable, and 30-day PE-related mortality. Results: A total of 248 patients were included in this analysis (150 with obesity and 98 who were in the normal/overweight category). Obesity was associated with a lower risk of 30-day PE-related mortality (adjusted HR 0.29, p = 0.036, 95% CI 0.09–0.92). A higher BMI was paradoxically associated with a lower risk of PE-related mortality (HR = 0.91 per 1 kg/m2 increase, p = 0.049, 95% CI 0.83–0.999). Conclusions: In our contemporary cohort of patients with a PERT activation, obesity was associated with a lower risk of PE-related mortality.

17 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SBSyed Bukhari
Syed Bukhari
SKSyed Zamrak Khan
Syed Zamrak Khan
MGMohamed Ghoweba
Mohamed Ghoweba
BKBilal Khan
Bilal Khan
ZBZubair Bashir
Zubair Bashir
Cardiac amyloidosis is caused by amyloid fibrils that deposit in the myocardial interstitium, causing restrictive cardiomyopathy and eventually death. The electromechanical, inflammatory, and autonomic changes due to amyloid deposition result in arrhythmias. Atrial fibrillation is by far the most common arrhythmia. Rate control strategy is generally poorly tolerated due to restrictive filling physiology and heart rate dependance, favoring adoption of rhythm control strategy. Anticoagulation for stroke prophylaxis is warranted irrespective of CHA2DS2Vasc score in patients with favorable bleeding profile; data on left appendage closure devices is still insufficient. Ventricular arrhythmias are also not uncommon and the role of implantable cardioverter-defibrillator in cardiac amyloidosis is controversial. There is no evidence of improvement in outcomes when used for primary prevention in these patients. Bradyarrhythmia is most commonly associated with sudden cardiac death in cardiac amyloidosis. Pacemaker implantation can help provide symptomatic relief but does not confer mortality benefit.

1 October 2024 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
YVYashashree Vegi
Yashashree Vegi
SKSri harsha Kanuri
Sri harsha Kanuri
MGMohamed Ghoweba
Mohamed Ghoweba
OAOgechi Agogbuo
Ogechi Agogbuo
LJLijo John
Lijo John
PBPaul Bradley
Paul Bradley

6 November 2024 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
OAOgechi Agogbuo
Ogechi Agogbuo
SKSri harsha Kanuri
Sri harsha Kanuri
LSLuis Salinas
Luis Salinas
MGMohamed Ghoweba
Mohamed Ghoweba
KVKhashayar Vahdat
Khashayar Vahdat
LFLarry Frase
Larry Frase
Vascular Ehler–Danlos disease (vEDS), a rare subtype of a rare disease, is a life-threatening disease, with an increased risk for spontaneous vascular or visceral rupture. These patients have fatal complications ranging from vascular aneurysms, dissection, and rupture of systemic vessels to frequent thromboembolic events, the common causes of death in these individuals with a shortened life span. In the present case, a 28-year-old male with history of shoulder dislocations and spontaneous colon perforation presented to the primary care clinic with right lower extremity swelling and pain. His history includes presentation to the emergency department with left lower leg swelling with compartment syndrome one year prior. A CT angiogram of lower extremities and abdomen revealed acute arterial extravasation of the left posterior tibial artery, indicating a ruptured aneurysm along with aneurysms of the splenic artery and left common iliac artery. He was treated with a saphenous vein graft, but was associated with post-operative complications that necessitated below-knee amputation. CT angiogram of his right leg revealed occlusion of the anterior tibial and peroneal arteries with aneurysms, and, ultimately, he was referred to a tertiary care center for aneurysm embolization. This case report emphasizes the frequent vascular complications encountered in vascular EDS patients, and thus advocates for close and regular monitoring for early referral and surgical management of their vascular anomalies. Finally, genetic counseling and screening of asymptomatic family members should be routinely implemented in these patients.